Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This multimodal perineal analgesia protocol (MPAP) is a combination therapy being evaluated by the University of Miami for the management of postoperative perineal pain following vaginal surgeries such as perineorrhaphy or posterior colporrhaphy. The protocol consists of three components: medicated witch hazel pads (e.g., MAJOR Medi-Pads), which act as an astringent to reduce inflammation and swelling; a 20% benzocaine spray (e.g., Dermoplast), a local anesthetic that provides temporary pain relief by blocking sodium channels; and perineal ice packs for cryotherapy. This combination aims to provide a non-opioid alternative for managing localized pain and discomfort in the immediate postoperative period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on witch hazel + benzocaine.